Change in circulating endothelial cells (CEC) predicts progression free survival (PFS) in patients (pts) with hormone receptor positive metastatic breast cancer (MBC) receiving letrozole (L) and bevacizumab (B) Meeting Abstract
| Authors: | Rugo, H. S.; Dickler, M. N.; Traina, T. A.; Scott, J. H.; Moore, D. H.; Bruckner, J.; Hudis, C.; Park, J. W. |
| Abstract Title: | Change in circulating endothelial cells (CEC) predicts progression free survival (PFS) in patients (pts) with hormone receptor positive metastatic breast cancer (MBC) receiving letrozole (L) and bevacizumab (B) |
| Meeting Title: | 42nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 24 |
| Issue: | 18 Suppl. Pt. 1 |
| Meeting Dates: | 2006 Jun 2-6 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2006-06-01 |
| Start Page: | 130S |
| Language: | English |
| ACCESSION: | WOS:000239009400509 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2006.24.18_suppl.3039 |
| Notes: | --- - Meeting Abstract: 3039 - 42nd Annual Meeting of the American-Society-of-Clinical-Oncology - JUN 02-06, 2006 - Atlanta, GA - S - Part 1 - "Source: Wos" |
Altmetric
Citation Impact
BMJ Impact Analytics
